Physician profile
George N Guild
NPI 1063680031
$987,485.94
in general payments reported to CMS, 2019-2025
20 companies · $615K in 2025
The $615K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $35K · 2021: $52K · 2022: $113K · 2023: $102K · 2024: $42K · 2025: $615K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $585K · Education: $71K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $58K · Travel and Lodging: $27K · Food and Beverage: $15K · Long Term Medical Supply Or Device Loan: $2,459 · Royalty Or License: $855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $584,915.64 |
| Education | $71,103.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $58,143.77 |
| Travel and Lodging | $27,164.43 |
| Food and Beverage | $14,862.60 |
| Long Term Medical Supply Or Device Loan | $2,459.02 |
| Royalty Or License | $855.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $619,618.77 | 2020-2025 | Persona, Mymobility Platform, Z1 Hip System |
| Smith+Nephew, INC. | $353,471.47 | 2019-2025 | Journey II, Real Intelligence, Redapt |
| Total Joint Orthopedics, INC. | $12,638.91 | 2019-2025 | |
| Kci USA, INC. | $262.50 | 2020 | |
| Osteoremedies, LLC | $216.57 | 2025 | Remedy Spectrum Gv Spacer, Biowash Surgical Irrigation, Remedy Spacer |
| Linkbio Corp | $184.80 | 2024 | |
| Medacta USA, INC. | $176.20 | 2024-2025 | Gmk Sphere |
| Becton, Dickinson and Company | $157.81 | 2024 | Arista Ah Flexitip |
| Stryker Corporation | $143.42 | 2019-2020 | |
| Heraeus Medical, LLC. | $112.49 | 2019 | |
| Heron Therapeutics, INC. | $106.18 | 2025 | Zynrelef |
| Pacira Therapeutics, INC. | $95.78 | 2021 | |
| Curonix LLC | $90.81 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Next Science LLC | $56.60 | 2024 | Surgx, Xperience, Blastx |
| Bioventus LLC | $49.44 | 2025 | Durolane |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $31.44 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $22.11 | 2024 | Zilretta, Iovera, Exparel |
| Ethicon US, LLC | $21.16 | 2025 | Vistaseal |
| Kuros Biosciences USA, INC | $15.11 | 2023 | |
| Access Pro Medical, LLC | $14.37 | 2025 | Matriderm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Guild listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.